432 related articles for article (PubMed ID: 14633995)
1. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
2. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.
Zhang Z; Wang H; Li M; Agrawal S; Chen X; Zhang R
J Biol Chem; 2004 Apr; 279(16):16000-6. PubMed ID: 14761977
[TBL] [Abstract][Full Text] [Related]
3. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
4. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
[TBL] [Abstract][Full Text] [Related]
5. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1.
Sato N; Mizumoto K; Maehara N; Kusumoto M; Nishio S; Urashima T; Ogawa T; Tanaka M
Anticancer Res; 2000; 20(2A):837-42. PubMed ID: 10810363
[TBL] [Abstract][Full Text] [Related]
7. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.
Touitou R; Richardson J; Bose S; Nakanishi M; Rivett J; Allday MJ
EMBO J; 2001 May; 20(10):2367-75. PubMed ID: 11350925
[TBL] [Abstract][Full Text] [Related]
8. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288).
Meng LH; Kohn KW; Pommier Y
Oncogene; 2007 Jul; 26(33):4806-16. PubMed ID: 17297446
[TBL] [Abstract][Full Text] [Related]
9. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
[TBL] [Abstract][Full Text] [Related]
10. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 stability by Mdm2.
Kubbutat MH; Jones SN; Vousden KH
Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
[TBL] [Abstract][Full Text] [Related]
12. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
[TBL] [Abstract][Full Text] [Related]
13. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
16. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
17. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
[TBL] [Abstract][Full Text] [Related]
18. Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations.
Dowell SP; McGoogan E; Picksley SM; el-Deiry WS; Vogelstein B; Hall PA
Cytopathology; 1996 Oct; 7(5):340-51. PubMed ID: 8911758
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
An WG; Hwang SG; Trepel JB; Blagosklonny MV
Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
[TBL] [Abstract][Full Text] [Related]
20. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
